Direxion Fallen Knives ET... (NIFE)
AMEX: NIFE
· Real-Time Price · USD
45.20
-1.18 (-2.54%)
At close: Jun 12, 2025, 3:42 PM
-2.54% (1D)
| Bid | - |
| Market Cap | 2.26M |
| AUM | 2.27M |
| NAV | 45.36 |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Shares Out | 50K |
| Inception Date | Jun 11, 2020 |
| Ask | - |
| Volume | 720 |
| Open | 44.77 |
| Previous Close | 46.38 |
| Day's Range | 44.77 - 45.20 |
| 52-Week Range | 44.77 - 45.20 |
| Holdings | 51 |
| Expense Ratio | 0.50% |
About NIFE
The fund, under normal circumstances, invests at least 80% of its assets in the securities that comprise the index or investments with economic characteristics similar to the securities included in the index. The index is designed by Indxx, LLC to consist of U.S. equity securities that have experienced considerable share price declines over the prior year but have financial health, suggesting that the security has potential for share price recovery in the future. It is non-diversified.
Asset Class Equity
Ticker Symbol NIFE
Inception Date Jun 11, 2020
Provider Direxion
Website Fund Home Page
Exchange AMEX
Top Sectors
| Sector | Weight % |
|---|---|
| Healthcare | 52.34% |
| Technology | 24.99% |
| Consumer Defensive | 8.69% |
| Consumer Cyclical | 7.49% |
| Energy | 2.84% |
Top 10 Holdings 50.78% of assets
| Name | Symbol | Weight |
|---|---|---|
| Pinterest, Inc. | PINS | 6.14% |
| Globus Medical, Inc. | GMED | 5.20% |
| Genmab A/s | GMAB | 5.16% |
| Crispr Therapeutics ... | CRSP | 5.15% |
| Abiomed, Inc. | ABMD | 5.11% |
| Plug Power Inc. | PLUG | 4.99% |
| Biontech Se | BNTX | 4.83% |
| Shopify Inc. | SHOP | 4.79% |
| Intuitive Surgical, ... | ISRG | 4.77% |
| Universal Display Co... | OLED | 4.64% |
Dividends Dividend Yield 5.67%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 9, 2021 | $2.8990 | Dec 16, 2021 |
| Sep 21, 2021 | $0.0570 | Sep 28, 2021 |
| Jun 22, 2021 | $0.2070 | Jun 29, 2021 |
| Mar 23, 2021 | $0.0740 | Mar 30, 2021 |
| Dec 22, 2020 | $0.1740 | Dec 30, 2020 |
2 years ago · etf.com
Direxion to Close 7 ETFs2022 has so far left eclipsed 2021 when it comes to closures.
